Zenas BioPharma, Bicara Therapeutics Sets IPO Price Ranges as Summer Lull Ends
Zenas BioPharma, Bicara Therapeutics Sets IPO Price Ranges as Summer Lull Ends
Zenas BioPharma和Bicara Therapeutics设定了首次公开发行价格范围，夏季低迷接近尾声。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间